Company intelligence
Fortrea
Bringing life-changing benefits to patients faster
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com
Verified activity
Signals from Fortrea
141 published signals
Presence & Recognition
Fortrea is attending the SCDM Annual Conference in Raleigh from September 14 to 17 to share insights and shape the future of clinical trials and clinical data management.
Reported by Fortrea
Presence & Recognition
Fortrea is attending the SCDM Annual Conference in Raleigh from September 14 to 17 to share insights and shape the future of clinical trials and clinical data management.
Reported by Adrienne Levandowski
Research & Knowledge
Fortrea published an Insights article by Anjani Gayatri exploring how investing in physical and mental health shapes work, challenges, and sustainable careers.
Reported by Philippa Graham
Research & Knowledge
Fortrea published an Insights article by Anjani Gayatri exploring how investing in physical and mental health shapes work, challenges, and sustainable careers.
Reported by Sarah Eggert
Presence & Recognition
Fortrea Vice President and Head of Regulatory Strategy Alicia Baker McDowell was featured in Clinical Research News to share her perspective on near-live data sharing for sponsors.
Reported by Philippa Graham
Research & Knowledge
Fortrea published a case study on optimizing the literature surveillance workflow to enhance market value communications.
Reported by Steven Dilworth
Research & Knowledge
Fortrea published an article sharing how a coordinated approach to referral networks, site activation, and cross-functional collaboration is helping shorten the wait for pulmonary fibrosis trials.
Reported by Steven Dilworth
People
Fortrea is hiring for a Clinical Trial Manager role for Gabriele.
Reported by Steven Dilworth
Presence & Recognition
Fortrea Vice President and Head of Regulatory Strategy Alicia Baker McDowell was featured in Clinical Research News to share her perspective on near-live data sharing for sponsors.
Reported by Nicole Given
Presence & Recognition
Fortrea hosted the Ophthalmology Perspectives podcast episode discussing patient recruitment in ophthalmology trials, featuring Amber Burg and Tanya Richardson and Lisa Liang.
Reported by Nicole Given
Presence & Recognition
Fortrea is attending the SCDM Annual Conference in Raleigh from September 14 to 17 to share insights and shape the future of clinical trials and clinical data management.
Reported by Nicole Given
People
Fortrea is hiring for a Clinical Trial Manager role for Gabriele.
Reported by Delphine Deschepper
Research & Knowledge
Fortrea shared insights from the 2026 iCAN Summit where children, adolescents and families shared perspectives on clinical research participation, study logistics and wellbeing support.
Reported by Delphine Deschepper
Research & Knowledge
Fortrea published a case study on optimizing the literature monitoring process to enhance market-value communications.
Reported by Delphine Deschepper
Research & Knowledge
Fortrea published an Insights article by Anjani Gayatri exploring how investing in physical and mental health shapes work, challenges, and sustainable careers.
Reported by Delphine Deschepper
Research & Knowledge
Fortrea published an early-stage trial showing that a single-dose experimental gene-editing therapy reduced bad cholesterol and triglycerides in patients for over a year.
Reported by Delphine Deschepper
Research & Knowledge
Fortrea published an Insights article by Anjani Gayatri exploring how investing in physical and mental health shapes work, challenges, and sustainable careers.
Reported by Hailey I.
Presence & Recognition
Fortrea announced that its Foundation for Success is a positive, resilient mindset.
Reported by Alec Spinelli MBA
People
Fortrea is hiring for a Clinical Trial Manager role for Gabriele.
Reported by Lisa Snyder
People
Fortrea celebrated Dania Rivero González 10 years of service at the company.
Reported by Helga de las Heras
Research & Knowledge
Fortrea shared insights from the 2026 iCAN Summit where children, adolescents and families discussed clinical research participation, study logistics, and wellbeing support.
Reported by Sarah Eggert
Presence & Recognition
Fortrea is attending the European Respiratory Society (ERS) conference in Barcelona, Spain from September 5 to 9.
Reported by Sarah Eggert
Presence & Recognition
Fortrea is attending the European Respiratory Society (ERS) meeting in Barcelona, Spain from September 5 to 9.
Reported by Philippa Graham
Presence & Recognition
Fortrea Senior Medical Director Dr. Amanda Nogueira is spotlighting late diagnosis, tumor heterogeneity, and the promise of FRα-targeted therapies at the Ovarian Cancer Awareness Month and ESMO2026 in Madrid.
Reported by Steven Dilworth